Pre-transplantation testing: Who, when and why?

Journal of Hospital Infection

Volumn 43, Issue SUPPL. 1, 1999, Pages

  Farrington, M ^a   Tedder, R ^b   Kibbler, C ^c   Wreghitt, T ^a   Gould, K ^d   Tremlett, C H ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cytomegalovirus; Haematopoietic stem cell transplantation; Heart lung transplantation; Organ procurement; Organ transplantation; Tissue banks

Indexed keywords

ACICLOVIR; GANCICLOVIR; GENTAMICIN; IMIPENEM; NYSTATIN; POLYMYXIN DERIVATIVE; VANCOMYCIN;

BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; SPUTUM ANALYSIS; TISSUE PRESERVATION; VIRUS ISOLATION;

HEART VALVES; HUMANS; INFECTION CONTROL; ORGAN TRANSPLANTATION; PATIENT SELECTION; PREOPERATIVE CARE; SPUTUM; STEM CELL TRANSPLANTATION; TISSUE BANKS; TISSUE DONORS;

EID: 0033395404     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(99)90094-4     Document Type: Conference Paper

References (24)

1. Koneman EW, Davis MA. Postmortem bacteriology: III. Clinical significance of microorganisms recovered at autopsy. Am J Clin Pathol 1974; 61: 28-40.
2. Khanna SK, Ross JK, Monro JL. Homograft aortic valve replacement: seven years experience with antibiotic-treated valves. Thorax 1981; 36: 330-337.
3. Yacoub M, Rasmi NR, Sindt TM et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995; 110: 186-193.
4. Staab ME, Nishimura RA, Dearani JA, Orszulak TA. Aortic valve homografts in adults: a clinical perspective. Mayo Clinic Proc 1998; 73: 231-238.
5. American Association of Tissue Banks. Standards for Tissue Banking. AATB, McLean, Virginia, USA; 1993.
6. Working Party of the UKTSSA and NIBSC. Promoting the safety of transplantation of human tissues and organs. United Kingdom Transplant Support Services, Bristol, United Kingdom; 1994.
7. British Association of Tissue Banks. Standards for Tissue Banking. BATB; 1995.
8. Hu J-F, Gilmer L, Hopkins R, Wolfinbarger L. Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovasc Res 1989; 23: 960-964.
9. Price AB, Owen R, Sowter G, Weinberg J, Smith H. Disseminated Mycobacterium xenopi infection. Lancet 1985; ii: 383.
10. Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Chia J, Jarvis WR. Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis 1998; 27: 688-691.
11. Farrington M, Hunt C, Matthews IM, Scarr D, Pegg D. Reducing microbial contamination of allograft heart valves. 38th Intersciences Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 1998 (abstract K-49b).
12. Wreghitt TG. Assessment of tests for detecting CMV antibody in transplant donors and recipients. Transpl Proc 1988; 20: 778.
13. Gray JJ, Alvey B, Smith DJ, Wreghitt TG. Evaluation of a commercial latex agglutination test for detecting antibodies to CMV in organ donors and transplant patients. J Virol Meth 1987; 16: 13-19.
14. Cohen A, Tepperberg M, Waters-Pick B et al. The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy. J Hematother 1996; 5: 289-294.
15. Rowley SD, Davis J, Dick J et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance. Transfusion 1988; 28: 109-112.
16. Lazarus HM, Magalhaes-Silverman M, Fox RM, Creger RJ, Jacobs M. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991; 7: 241-246.
17. Farrington M, Matthews I, Marcus R, Scott MA, Caffrey E, Hunt CJ. Contamination of bone marrow transplants from peripheral blood. Brit Med J 1994; 309: 958.
18. FACHT, ISHAGE, ASBMT. Joint position paper on the regulatory approach to hematopoietic cell components in the United States. J Hematother 1997; 6: 91-92.
19. JACIE. Standards for blood and marrow progenitor cell processing, collection and transplantation. 4th Edition, 1998.
20. NHS Executive. Guidance notes on the processing, storage and issue of bone marrow and blood stem cells. HSG(97)19, Department of Health, 1997.
21. Singh N. State of the Science. Infections in solid-organ transplant recipients. Am J Infect Control 1997; 25: 409-417.
22. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: 15th Official Report, 1998. J Heart Lung Transplant 1998; 17: 656-668.
23. Low DE, Kaiser LR, Haydock DA, Trulock E, Cooper JD. The donor lung: Infectious and pathologic factors affecting outcome in lung transplantation. J Thoracic Cardiovasc Surg 1993; 106: 614-621.
24. Waller DA, Thompson AM, Wrightson WN et al. Does the mode of donor death influence the early outcome of lung transplantation? A review of lung transplantation from donors involved in major trauma. J Heart Lung Transplant 1995; 14: 318-321.